The Prognostic Value of Biomarkers on Detecting Non-Small Cell Lung Cancer in a Chinese Elderly Population
Lianghua Guo,Bin Song,Jianhong Xiao,Hui Lin,Junhua Chen,Xianghua Su
DOI: https://doi.org/10.2147/IJGM.S331311
IF: 2.145
2021-09-07
International Journal of General Medicine
Abstract:Lianghua Guo, 1 Bin Song, 1 Jianhong Xiao, 1 Hui Lin, 1 Junhua Chen, 1 Xianghua Su 2 1 Department of Respiratory Medicine, Mindong Hospital of Fujian Medical University, Fuan City, 355000, People's Republic of China; 2 Department of Neurosurgery, Mindong Hospital of Fujian Medical University, Fuan City, 355000, People's Republic of China Correspondence: Xianghua Su Department of Respiratory Medicine, Mindong Hospital of Fujian Medical University, No. 89 Heshan Road, Fuan City, 355000, Fujian Province, People's Republic of China Email Background: Survival in non-small cell lung cancer (NSCLC) remains poor. Early detection of NSCLC is of great significance to provide a chance to improve survival. Aim: We constructed predictive models to evaluate the predictive value of four tumor biomarkers by including serum human epididymis protein 4 (HE4), carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCCA), and cytokeratin 19 fragment (CY21-1) on detecting NSCLC in a Chinese elderly population. Methods: A total of 363 patients with NSCLC and 433 subjects without cancer (healthy control group) were admitted to the respiratory department in our hospital. We assessed serum levels of these four tumor biomarkers in the two groups and then the predictive value of predictive models was evaluated. Results: Serum median values of HE4 (143.3 pmol/L), CEA (4.60 ng/mL), SCCA (1.52 ng/mL), and CY21-1 (5.36 ng/mL) in patients with NSCLC were significantly higher than the healthy control group, respectively (all P < 0.05). A multivariate logistic regression model showed that HE4 (OR=2.10, 95% CI=1.22– 4.42, P =0.013), CEA (OR=2.30, 95% CI=1.44– 4.53, P =0.004), SCCA (OR=2.20, 95% CI=1.29– 4.55, P =0.011), and CY21-1 (OR=2.60, 95% CI=1.56– 6.25, P < 0.001) were significantly and independently associated with increased risk of NSCLC on admission after confounding factors were corrected. Importantly, the ROC curve suggested HE4 had a good value on predicting NSCLC in the Chinese elderly population. Additionally, the predictive model (CEA+SCCA+CY21-1+HE4) had better idea capability to detecting the existence of NSCLC (AUC=0.954, 95% CI=0.927– 0.999, P < 0.001). Conclusion: Our study showed that several lung cancer-related biomarkers were used to build prediction models, which has good value for early prediction of NSCLC. Keywords: NSCLC, HE4, CEA, SCCA, CY21-1, Chinese elderly population, predictive value As one of the common malignant tumors, lung cancer has become the first cause of death in an urban population on a worldwide scale. 1 Non-small cell lung cancer (NSCLC) accounts for about 80% of all lung cancer in China. 1,2 Although the diagnosis and molecular targeted therapy have been developed, about 75% of these patients with NSCLC are in advanced stage and the survival rate of 5 years has not improved significantly. 2 Currently, some non-specific tumor biomarkers, including squamous cell carcinoma antigen (SCCA), carcinoembryonic antigen (CEA) and cytokeratin 19 fragment (CYFRA 21–1), can improve the sensitivity of diagnosis for NSCLC, but the specificity is still low. 3,4 Diagnosed NSCLC at an early stage can greatly improve the survival rate of these patients. Therefore, it is necessary to find new serum biomarkers or predictive models that can early and accurately predict the prevalence of NSCLC, providing the treatment opportunity and prolonging survival time for these patients. 5 Human epididymis protein 4 (HE4), also known as whey-acidic-protein four disulfide core protein-2 (WFDC2), has been considered as a new and promising tumor biomarker, 6 and the food and drug administration (FDA) has approved serum HE4 as the biomarker for early diagnosing and monitoring of ovarian cancer. 7,8 HE4 is also a protease inhibitor with protective immunity, involved in sperm maturation in the epididymis epithelium. At present, overexpression of HE4 protein has also been identified in other tumor tissues, like lung cancer, 9 and high HE4 expression was associated with more serious and shorter survival time. 10–12 For instance, it has been suggested that HE4 is involved in immune defense and inflammatory response in the oral cavities, nasal and respiratory tract in the development of lung adenocarcinoma. 13–15 Some published studies also suggested that HE4 expression was associated with the progression of lung cancer. 13–19 However, investigations of HE4 in NSCLC are still few. In this study we analyzed serum biomarkers (HE4, CEA, SCCA, and CY21-1) in 363 patients with -Abstract Truncated-
medicine, general & internal